Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term IgPro20 (Hizentra) in Primary Immunodeficiency
NCT01461018Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Oct 2011
- Primary completion
- Jul 2014
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Oct 2011; status: completed.
02
Drugs
IgPro10
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT01461018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01461018.